{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-017651","form_type":"8-K","ticker":"CTNM","cik":"0001855175","company_name":"Contineum Therapeutics, Inc.","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.887001+00:00","generated_at":"2026-06-01T13:18:09.266003+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Contineum Therapeutics appoints Troy Ignelzi to board as Audit Committee Chair","bullets":["Troy Ignelzi appointed as Class I director and Chair of Audit Committee, effective May 20, 2024.","Evert Schimmelpennink stepped down from Audit Committee; Class I directors now Ignelzi and Olivia Ware.","Ignelzi is CFO of Rapport Therapeutics; previously CFO at Karuna Therapeutics, scPharma, Juventas.","Ignelzi will receive standard non-employee director compensation including an option for 23,150 shares.","Board determined Ignelzi independent and an audit committee financial expert under SEC/Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-017651","json":"https://secwatch.observer/filing/0001437749-24-017651.json","markdown":"https://secwatch.observer/filing/0001437749-24-017651.md","text":"https://secwatch.observer/filing/0001437749-24-017651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/0001437749-24-017651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/cont20240420_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T13:18:09.266003+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"54081fe356","claim":"Troy Ignelzi was appointed as Class I Director and Chair of Audit Committee at Contineum Therapeutics, Inc..","evidence_excerpt":"On May 20, 2024, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Troy Ignelzi as a member of its Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924017651/0001437749-24-017651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director and Chair of Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}